Please assess the completion status of the following clinical trial:

Trial Title: Lidocaine and Ketamine Versus Standard Care on Acute and Chronic Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Age greater than 18 and less than 75 years~* Male~* Unilateral inguinal hernia scheduled for elective open repair~Exclusion Criteria:~* Incarcerated hernia or urgent procedure~* Reoperation (recurrent hernia)~* Contraindication to regional anesthesia such as:~* Coagulopathy~* Infection at the site of needle insertion~* Pre-existing chronic pain (at any site) requiring treatment~* Contraindication to any study medication (local anesthetic or ketamine)~* History of significant Axis I psychiatric disease (major depressive disorder,bipolar disorder, schizophrenia, etc.)~* Significant hepatic (ALT or AST \> 2 times normal) or renal (serum creatinine \> 2 mg/dl) impairment

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Ropivacaine (Type: ACTIVE_COMPARATOR): Paravertebral Group - A local anesthetic (ropivacaine) will be injected near the spine before surgery. Participants will also receive midazolam and fentanyl intravenously (through your vein) for sedation
- Lidocaine/ketamine (Type: ACTIVE_COMPARATOR): Participant will receive general anesthesia through the vein before surgery. Lidocaine and ketamine will be administered intravenously throughout surgery and for 60 minutes after surgery.
- Placebo (Type: PLACEBO_COMPARATOR): General anesthesia plus placebo. Placebo will be administered intravenously until 60 minutes after surgery

Based on this trial design, predict the completion outcome and termination type (if applicable).